logo
  •   Home
  • Applications
    • Indications
  • Business
  • EpiSwitch®
  • Products
    • EpiSwitch® Checkpoint Inhibitor Response Test
    • EpiSwitch® COVID-19 Severity Test
    • EpiSwitch® Explorer Array Kit
    • EPISWITCH® ANALYTICAL PORTAL
    • EpiSwitch® Service
  • Investors
    • Investors Overview
    • Results and Presentations
    • Share Price Information
    • Regulatory News
    • Board & Governance
    • Key Corporate Documents
    • AIM Rule 26
    • Email Alerts
    • Investor Contacts
  • News
  • About Us
    • History
    • Board of Directors
    • Management Team
    • Scientific Advisory Panel
    • Values
    • Careers
    • Contact Us

Episwitch Publication

Genomic Architecture Differences at the HTT Locus Associated with Symptomatic and Pre-Symptomatic Cases of Huntington’s Disease in a Pilot Study

Psychiatry Open Access


by Aroul Ramadass

3D genomic capture of regulatory immuno-genetic profiles in COVID-19 patients for prognosis of severe COVID disease outcome

bioRxiv, March 2021


by oxfordbiodynamics

Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups.

J Transl Med 19, 46 (2021)


by Aroul Ramadass

A conversation about Systemic Sclerosis

EBR, Autumn 2020


by Aroul Ramadass

The Prospective Study of Epigenetic Regulatory Profiles in Sport and Exercise Monitored Through Chromosome Conformation Signatures

Genes 2020, 11(8), 905


by Aroul Ramadass

Comparative molecular cell-of-origin classification of diffuse large B-cell lymphoma based on liquid and tissue biopsies

Translational Medicine Communications volume 5, Article number: 5 (2020)


by Aroul Ramadass

Development and validation of baseline predictive biomarkers for response to immuno-checkpoint treatments in the context of multiline and multitherapy cohorts using EpiSwitch® epigenetic profiling

SITC, J. Immunotherapy Cancer 7, 282 (2019) P143


by oxfordbiodynamics

Development and validation of baseline predictive biomarkers for response to avelumab in second-line (2L) non-small cell lung cancer(NSCLC) using EpiSwitch® epigenetic profiling

SITC, J. Immunotherapy Cancer 7, 282 (2019) P142


by oxfordbiodynamics

Ectopic gene deregulations and chromosome conformations: integrating novel molecular testing into clinical applications, from leukemias to gliomas

Handbook of Biomarkers and Precision Medicine, 1st Edition


by Aroul Ramadass

Epigenetic chromatin conformation changes in peripheral blood can detect thyroid cancer.

Surgery (2018) Oct 27. pii: S0039-6060(18)30622-6


by Aroul Ramadass

  • 1
  • 2
  • 3
  • …
  • 5

Terms of Use / Site Map / Privacy Policy / Cookies Policy

Regulated and Licensed by Human Tissue Authority
License No. 12571
© 2002-2021 Oxford Biodynamics Plc

Privacy Preference Center

Privacy Preferences